Advertisement

Gracell Biotechnologies Inc. GRCL

Set alert

Price alert · GRCL

All alert types
10.25 +10.25 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
989.87M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-56.94
Beta
-0.34
Short ratio
0.87
Inst. own
63.11%
Dividend
0.00
Ex-div date
Earnings
Mar 11, 2024
50-d avg
9.54
200-d avg
5.24
1y target
10.58

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for GRCL has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $2.18MOther Operating Income → Expenses: $733.00KExpenses → Selling, General & Admin: $42.86MExpenses → Research & Development: $88.62MExpenses → Interest Expense: $1.09MGross Profit → Expenses: $366.00KRevenue → Gross Profit: $366.00KNet Loss → Expenses: $129.28MOther Income$2.18MOther Operating Income$733.00KGross Profit$366.00KNet Loss$129.28MExpenses$132.57MSelling, General & Admin$42.86MResearch & Development$88.62MInterest Expense$1.09MRevenue$366.00K

Period ending Jun 30, 2023 · select a line to chart its history

Income statement

GRCL quarterly income statement
339.95M

Balance sheet

GRCL quarterly balance sheet
1.18B
163.60M
3.57M
3.57M
1.25B
119.59M
1.38B
115.48M
157.98M
193.82M
42.50M
241.17M
-1.92B
118.09M
1.14B
157.01M
130.48M
21.82M
47.35M
2.76M
Advertisement